Heart Disease News and Research

Latest Heart Disease News and Research

Internet-based CBT as effective as group therapy for treating panic disorder

Cognitive behaviour therapy (CBT) via the internet is just as effective in treating panic disorder (recurring panic attacks) as traditional group-based CBT. It is also efficacious in the treatment of mild and moderate depression. This according to a new doctoral thesis soon to be presented at the Swedish medical university Karolinska Institutet.

12 Apr 2010

Sun Pharmaceutical Industries' generic Namenda ANDA: USFDA grants tentative approval

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.

12 Apr 2010

Johns Hopkins Hospital launches Meatless Monday campaign to encourage healthier

The Johns Hopkins Hospital will launch a campaign on Monday, April 12 to encourage healthier eating among patients, visitors and staff — Meatless Monday.

12 Apr 2010

Resverlogix highlights features of RVX-208 drug at ATVB conference

Resverlogix Corp. announced today that key scientific data was communicated in an oral presentation highlighting the novel features of RVX-208, the Company's lead drug, during the Atherosclerosis, Thrombosis, Vascular Biology conference being held in San Francisco, California.

12 Apr 2010

Renal specialist says Dr Patel’s patient was too frail for surgery

In the ongoing trial of Dr Jayant Patel, Dr Peter Miach, a renal specialist, gave evidence before the Supreme Court in Brisbane. Dr Miach said the patient James Phillips had too many other problems and he would not have recommended surgery for him in his frail state.

12 Apr 2010

Study pioneers phenotyping of human metabolome

The old excuse, "I am only overweight because of my genes," is suddenly gaining credibility as researchers uncover ever more evidence that the way our bodies digest and process nutrients in the food we eat is different for every person. The budding discipline of metabolomics strives to investigate these differences in a scientific manner.

12 Apr 2010

Research roundup: The effects of health IT, doctor-owned treatment centers, long-term care issues

Physician-Ownership Of Ambulatory Surgery Centers Linked To Higher Volume Of Surgeries - The authors analyzed data from Florida, using the Healthcare Cost and Utilization Project's State Ambulatory Surgery Databases, revealing "a significant association between physician-ownership of surgicenters and greater use" of certain outpatient procedures.

9 Apr 2010

IMAGE project to be launched for prevention of type 2 diabetes

Researchers and clinicians from across the UK have been part of a pan-European team that has developed the first Europe wide strategy for the prevention of type 2 diabetes. The project received substantial funding of -1.2 million from the European Union.

9 Apr 2010

Penwest Pharmaceuticals signs drug development and commercialization agreement with Alvogen

Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.

9 Apr 2010

Broken heart disease affects women in post menopause period

It seems an infarction, but it's not. It's called Tako-Tsubo syndrome, or stress-induced cardiomyopathy, and it's a rare disease which at first used to be confused with the far more common (and dangerous) cardiac infarction. Patients arrive to the emergency room with the characteristic heart attack symptoms: acute pain in the chest, an electrocardiogram with the typical changes and the release of those enzymes associated with the usual heart disease.

9 Apr 2010

BIBA Research's TAVI report to be released

BIBA Research, the UK-based market research specialists for the medical technology industry, announced today that the latest findings from their Transcatheter Heart Valve report will be released on 26 April. The report covers the data period January-March 2010 and is part of BIBA Research's long-established European Cardiovascular Monitor.

9 Apr 2010

Mayo Clinic researchers to present XOMA 052 data at 101st AACR Annual Meeting

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that researchers from the Mayo Clinic will be presenting data on the use of XOMA's high-affinity antibody to interleukin-1 beta (IL-1 beta), XOMA 052, in myeloma at the 101st Annual Meeting of the American Association of Cancer Research (AACR).

9 Apr 2010

Cordis commences enrollment in safety trial of INCRAFT stent graft system for AAA

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technologies, announced today that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system, called INCRAFT™, to treat abdominal aortic aneurysm (AAA). An estimated 27 million people worldwide have abdominal aortic aneurysms.

9 Apr 2010

RNAO announces winners of 2010 Awards for Excellence in Health-Care Reporting

The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.

9 Apr 2010

Magnetic targeting may enhance effectiveness of stem cell therapies for heart injuries

Researchers at the Cedars-Sinai Heart Institute have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart's retention of those cells and could increase the therapeutic benefit of stem cell therapy for heart disease.

9 Apr 2010

Scientist develops SAMON system to diagnose apnea-hypopnea sleep syndrome

The sleep study or test is key for diagnosing apnea-hypopnea syndrome but, given its high cost, few resources are earmarked to it. Computer scientist at the University of the Basque Country, Mr Alfredo Burgos, has presented a thesis that aims to solve this problem.

9 Apr 2010

Zeria to market, distribute, and sell HemCon's wound and oral care dressings in Japan

HemCon Medical Technologies, Inc., an innovative developer of advanced medical products, is proud to announce the signing of an exclusive licensing agreement with Zeria Pharmaceuticals Co. Ltd., a leading pharmaceutical and consumer healthcare products company. Through this partnership, Zeria will market, distribute, and sell HemCon's line of revolutionary wound and oral care dressings throughout Japan.

9 Apr 2010

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

A five-year, $3.7 million clinical trial will investigate how to balance the benefits and risks of warfarin, a drug that helps prevent potentially deadly blood clots.

9 Apr 2010

Omega-3 fatty acids improve nerve regeneration, prevent psychotic disorders and reduce cellular aging

Improving nerve regeneration after corneal surgery, preventing psychotic disorders in those at high risk for them and reducing cellular aging are three emerging benefits of the omega-3 fatty acids found in seafood, according to milestone research described in the April 2010 PUFA Newsletter and Fats of Life online publications for health professionals and consumers, respectively.

9 Apr 2010

Six EDs across New York begin using Rochester RHIO

Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services and Rochester RHIO, the regional health information organization connecting medical providers across nine counties in New York, today announced that six emergency departments are using Rochester RHIO to view critical patient information from data providers across the region. Emergency departments (ED) include Clifton Springs, F.F. Thompson, Lakeside Memorial, Rochester General, United Memorial Medical Center, and Wyoming Community Hospitals.

9 Apr 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Internet-based CBT as effective as group therapy for treating panic disorder

Sun Pharmaceutical Industries' generic Namenda ANDA: USFDA grants tentative approval

Johns Hopkins Hospital launches Meatless Monday campaign to encourage healthier

Resverlogix highlights features of RVX-208 drug at ATVB conference

Renal specialist says Dr Patel’s patient was too frail for surgery

Study pioneers phenotyping of human metabolome

Research roundup: The effects of health IT, doctor-owned treatment centers, long-term care issues

IMAGE project to be launched for prevention of type 2 diabetes

Penwest Pharmaceuticals signs drug development and commercialization agreement with Alvogen

Broken heart disease affects women in post menopause period

BIBA Research's TAVI report to be released

Mayo Clinic researchers to present XOMA 052 data at 101st AACR Annual Meeting

Cordis commences enrollment in safety trial of INCRAFT stent graft system for AAA

RNAO announces winners of 2010 Awards for Excellence in Health-Care Reporting

Magnetic targeting may enhance effectiveness of stem cell therapies for heart injuries

Scientist develops SAMON system to diagnose apnea-hypopnea sleep syndrome

Zeria to market, distribute, and sell HemCon's wound and oral care dressings in Japan

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

Omega-3 fatty acids improve nerve regeneration, prevent psychotic disorders and reduce cellular aging

Six EDs across New York begin using Rochester RHIO

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in